<?xml version="1.0" encoding="UTF-8"?>
<p id="par0130">Relative liver weight was significantly increased by APAP injection compared to that in the control group (
 <italic>P</italic> &lt; 0.01); however, both the silymarin and GMSYS 1400 mg/kg/day treatments significantly lowered the relative liver weight compared to that in the APAP group (
 <xref rid="fig0010" ref-type="fig">Fig. 2</xref>b, 
 <italic>P</italic> &lt; 0.01). Relative kidney weight was significantly decreased in the APAP group compared to the control group (
 <italic>P</italic> &lt; 0.01); however, this sign was alleviated in the silymarin or GMSYS treatment groups (
 <xref rid="fig0010" ref-type="fig">Fig. 2</xref>c).
</p>
